RemSleep Holdings Inc.
RemSleep Holdings Inc. develops and sells sleep-apnea-related products, including the DeltaWave CPAP interface and earlier CPAP machine offerings. The company is based in the United States and operates through its REMSleep subsidiary and related intellectual property around sleep-therapy devices.
Fiscal year 2025 · change from previous year
Development 2020–2025
Business
Share of revenueNasal-pillows style interface designed to deliver CPAP therapy for sleep apnea patients.
Earlier respiratory therapy equipment sold before the product transition.
Design and development of new interfaces and related OSA treatment products.
Customers
The company sells to sleep-apnea patients through the respiratory-therapy and durable-medical-equipment channel, where comfort and usability are important purchase drivers. Its products are aimed at CPAP users and patients with obstructive sleep apnea who need an interface that improves tolerance and compliance. Clinical and distribution partners are also relevant because product adoption depends on validation and access to treatment channels.
Buy the DeltaWave interface to improve comfort, reduce claustrophobia, and support adherence to therapy.
Need sleep-apnea treatment devices that fit comfortably and support nightly use.
Distribute respiratory products to end users and influence product availability.
Support testing, validation, and broader acceptance of the product line.
Strategy
The company’s strategy is centered on commercializing the DeltaWave interface and building adoption in the sleep-apnea market. Management also highlights clinical trials, patent protection, and external financing as necessary steps to support product validation and sales growth.
The product is the core revenue opportunity and the basis for market entry.
Clinical evidence can improve adoption by patients, clinicians, and distributors.
Patents help defend the design and support differentiation in a niche device market.
Geography
RemSleep is a U.S.-based company, and the disclosed operating activity in the excerpts is centered on the United States. The reports do not provide a country revenue split, so the business should be viewed as primarily domestic based on available disclosure. Geography matters mainly through U.S. regulatory, reimbursement, and distribution channels for sleep-therapy devices.
Risks
The company faces going-concern and financing risk because it has relied on external capital to support operations and product development. It also faces commercialization risk typical of medical-device startups, including adoption uncertainty, clinical validation risk, and competition from established CPAP mask and interface makers.
The company states it has not generated sufficient cash flow and needs new funding.
Exposure: Operations and product development funding
Revenue depends on market acceptance of a new CPAP interface product.
Exposure: DeltaWave sales
Planned clinical trials may not confirm expected effectiveness or usability benefits.
Exposure: Product credibility and regulatory/commercial acceptance
The sleep-apnea device market includes established brands and distribution networks.
Accounting
Judgemental itemsDevice sales are recognized when products are sold, making results sensitive to shipment timing.
Impact: Quarterly revenue can be lumpy and hard to compare period to period
Product development and testing costs affect reported operating losses.
Impact: Changes in development activity can materially alter expense trends
Management states substantial doubt about continued operations without financing.
Impact: Important for assessing liquidity, valuation, and financial statement reliability
Similar listed companies
Publicly listed companies with a comparable business focus.
ResMed Inc
RMD · Surgical & Medical Instruments & Apparatus
Inspire Medical Systems, Inc.
INSP · Surgical & Medical Instruments & Apparatus
Inspire Medical Systems develops and commercializes a minimally invasive neurostimulation therapy for obstructive sleep apnea.
Sleep Cycle
SLEEP · Technology
Sleep Cycle is a technology company focused on improving global health by enhancing sleep quality through advanced sleep analysis and personalized insights.
Somnigroup International Inc
SGI · Household Furniture
Nyxoah SA
NYXH · Surgical & Medical Instruments & Apparatus
Nyxoah SA is a medical technology company focused on neuromodulation-based treatments for obstructive sleep apnea.
Purple Innovation, Inc.
PRPL · Household Furniture
Last updated: 29/04/2026